Advertisement

Topics

Towers Watson and Acclaris Company Profile

10:17 EST 13th December 2018 | BioPortfolio

Towers Watson (NASDAQ: TW) is a leading global professional services company that helps organizations improve performance through effective people, risk and financial management. With 15,000 associates around the world, the company offers consulting, technology and solutions in the areas of benefits, talent management, rewards, and risk and capital management. Learn more at towerswatson.com.


News Articles [92 Associated News Articles listed on BioPortfolio]

STAT Plus: IBM’s Watson supercomputer recommended ‘unsafe and incorrect’ cancer treatments, internal documents show

Slide decks presented last summer by an IBM Watson Health executive largely blame the problems on the training of Watson for Oncology by IBM engineers and doctors at the renowned…

How Labour’s Tom Watson lost over seven stone in a year to beat diabetes – Metro

MetroHow Labour's Tom Watson lost over seven stone in a year to beat diabetesMetroLabour Deputy Leader Tom Watson has revealed he lost an incredible seven stone in a year after radically changing his ...

STAT Plus: IBM Watson Health hampered by internal rivalries and disorganization, former employees say

When IBM launched its Watson Health division three years ago, promising to revolutionize medicine, not everyone in the sprawling technology company was on board.

Nonfiction: Christie Watson Is a Lovely Writer — and, Judging From This Book, a Gifted Nurse

In the memoir “The Language of Kindness,” Watson — better known as a novelist — looks back at her two decades as a nurse at an urban British hospital.

IBM Watson Health chief leaves role

Deborah DiSanzo, who has served as general manager of IBM Watson Health since 2015, is stepping down from her position and heading to the strategy team for IBM Cognitive Solutions, according to STAT.

STAT Plus: How an IBM Watson Health rescue mission collapsed — and a top executive was ousted

IBM couldn't get its Watson software to reliably understand and analyze language in patient medical records, a critical task for delivering on its contracts with hospitals and drug companies.

7 Jahre nach Watson macht IBM wieder von sich reden

Watson, eine von International Business Machines (WKN:851399) entwickelte künstliche Intelligenz, machte 2011 Schlagzeilen, indem sie zwei Champions in der US-Gameshow Jeopardy! besiegte. Diese ers.....

Health care startups make up majority of IBM Watson AI XPrize finalists

The IBM Watson AI XPrize competition has announced its list of 10 finalists, seven of which are artificial intelligence-focus -More- 

Drugs and Medications [59 Associated Drugs and Medications listed on BioPortfolio]

Cormax [Watson Pharma, Inc. ]

70010599meclizine hcitablets usprx only [Watson Laboratories, Inc.]

70010599Meclizine HCITablets USPRx only

Chlorzoxazone [Watson Laboratories, Inc.]

CHLORZOXAZONE TABLETS, USP 500 mg Revised:  November 2010 Rx only 195609

Chlorzoxazone [Watson Laboratories, Inc.]

CHLORZOXAZONE TABLETS, USP 500 mg Revised:  November 2010 Rx only 195609

Hydroxocobalamin [Watson Laboratories, Inc.]

HYDROXOCOBALAMIN INJECTION USP Rx only

PubMed Articles [35 Associated PubMed Articles listed on BioPortfolio]

The 5-oxyacetic acid modification destabilizes double helical stem structures and favors anionic Watson-Crick like cmo5U-G base pairs.

: Watson-Crick like G-U mismatches with tautomeric Genol or Uenol bases can evade fidelity checkpoints and thereby contribute to translational errors. The 5-oxyacetic acid uridine (cmo5U) modification...

ON THE COOPERATIVITY EFFECT IN WATSON&CRICK AND WOBBLE PAIRS FOR A HALOURACIL SERIES AND ITS POTENTIAL QUANTITATIVE APPLICATION STUDIED THROUGH SERS.

The nature of the cooperativity effect of hydrogen bonds in Watson & Crick and wobble base pairs formed with thymine, uracil and its 5-halogenated derivatives (5-fluoro, -chloro and -bromouracil) have...

Young children fail to generate an additive ratchet effect in an open-ended construction task.

The ratchet effect-the gradual accumulation of changes within a cultural trait beyond a level that individuals can achieve on their own-arguably rests on two key cognitive abilities: high-fidelity soc...

Contributions of Jean Watson's theory to holistic critical thinking of nurses.

to reflect on the contributions of Jean Watson's theory to the nurses' holistic critical thinking.

Usefulness of Watson's Caring Science for Online Educational Practices in Disciplines Outside of Nursing.

Human caring has long been considered the primary domain of nurses and the primary function of nursing practice. Results related to the study of a Caring Science, Mindful Practice Massive Open Online ...

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Clinical Concordance Study Between Watson for Oncology and Clinician Practice

At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a doubl...

Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State

The objective of this study was to investigate the bioequivalence of Genpharm's baclofen tablets following a single, oral 20 mg (1 x 20 mg) dose compared to the Baclofen USP (Watson Labora...

A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatmen

A multi-center, double-blind, randomized, placebo controlled, parallel-group study, comparing Clindamycin phosphate vaginal cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™,...

Comparison of Two Minimally Invasive Surgical Techniques for Hip Replacement

Comparison of the clinical effectiveness and cost-effectiveness of the MIS anterolateral approach (MIS Watson Jones, G3) versus anterolateral mini or posterolateral mini approaches in prim...

Companies [28 Associated Companies listed on BioPortfolio]

Towers Watson and Acclaris

Towers Watson (NASDAQ: TW) is a leading global professional services company that helps organizations improve performance through effective people, risk and financial management. ...

Towers Watson

Towers Watson (NYSE, NASDAQ: TW) is a leading global professional services company that helps organizations improve performance through effective people, risk and financial manage...

Acclaris

Acclaris simplifies the administration of consumer-driven healthcare for HR outsourcers, benefits administrators, financial institutions and health plans. The company offers finan...

Watson Inc.

Watson is one of the highest quality suppliers of products and services geared towards enhancing human health and nutrition around the world. We are a leader in developing quality...

Towers Perrin

Towers Perrin is a global professional services firm that helps organizations improve their performance through effective people, risk and financial management. The firm provides ...

More Information about "Towers Watson and Acclaris" on BioPortfolio

We have published hundreds of Towers Watson and Acclaris news stories on BioPortfolio along with dozens of Towers Watson and Acclaris Clinical Trials and PubMed Articles about Towers Watson and Acclaris for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Towers Watson and Acclaris Companies in our database. You can also find out about relevant Towers Watson and Acclaris Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record